Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
156studies shown
Showing 49-60 of 156
Other study type icon
RecruitingISRCTN73157235

Effects of a prenatal program group led to parental couples to prevent postpartum depression in women of middle and lower classes living in northern Catalonia and Southern France [Effetsd’unprogrammeprénatal de groupeadresséauxcouplesparentauxpourprévenir la dépressionpostnatale des femmes de clases moyenne et défavoriséehabitant en Catalogne Nord et en France Sud]

This study is recruiting in France and in Spain. It focuses on depression.

In France
DepressionOther
Countries
France, Spain
Sponsor
ADERMNCN (Association for better childbirth in Northern Catalonia) (Spain)
Condition
Depression
Other study type icon
RecruitingISRCTN44737909

Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in people with major depressive disorder: a six-week parallel group study versus comparator, followed by a optional treatment extension period up to six months

This study is recruiting in Australia, in France, in the United Kingdom, .... It focuses on depression.

In France
DepressionOtherOver 18 Years
Countries
Australia, France, United Kingdom, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
Other study type icon
RecruitingISRCTN28588282

Agomelatine given orally compared to placebo, for depression

This study is recruiting in France. It is testing agomelatine given orally compared to placebo, for depression.

In France
Depression, BipolarityOtherOver 18 Years
Countries
France
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression, Bipolarity
Other study type icon
RecruitingISRCTN49376288

Efficacy of agomelatine given orally on rest/activity circadian rhythms in outpatients with major depressive disorder: a international study with parallel groups versus Selective Serotonin Reuptake Inhibitor (SSRI). Six-week treatment plus optional continuation for 18 weeks.

This study is recruiting in France, in Austria, in Germany, .... It focuses on depression.

In France
DepressionOtherFrom 18 Years to 60 Years
Countries
France, Austria, Germany, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
France | Clinical Trials | HopeStage Research